Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
2.
Respir Care ; 68(4): 520-523, 2023 04.
Artículo en Inglés | MEDLINE | ID: covidwho-2249426

RESUMEN

BACKGROUND: Vocal cord dysfunction is an upper-airway disorder characterized by exaggerated and transient glottic constriction causing respiratory and laryngeal symptoms. Common presentation is with inspiratory stridor often in the context of emotional stress and anxiety. Other symptoms include wheezing (which may be on inspiration), frequent cough, choking sensation, or throat and chest tightness. This is seen commonly in teenagers, particularly in adolescent females. The COVID-19 pandemic has been a trigger for anxiety and stress with an increase in psychosomatic illness. Our objective was to find out if the incidence of vocal cord dysfunction increased during COVID-19 pandemic. METHODS: We performed a retrospective chart review of all the subjects with a new diagnosis of vocal cord dysfunction who were seen at the out-patient pulmonary practice at our children's hospital between January 2019-December 2020. RESULTS: The incidence of vocal cord dysfunction in 2019 was found to be 5.2%, (41/786 subjects seen) compared to 10.3% (47/457 subjects seen) in 2020, which is a nearly 100% increase in incidence (P < .001). CONCLUSIONS: It is important to recognize that vocal cord dysfunction has increased during the COVID-19 pandemic. In particular, physicians treating pediatric patients, as well as respiratory therapists, should be aware of this diagnosis. It is imperative to avoid unnecessary intubations and treatments with bronchodilators and corticosteroids as opposed to behavioral and speech training to learn effective voluntary control over the muscles of inspiration and the vocal cords.


Asunto(s)
COVID-19 , Disfunción de los Pliegues Vocales , Femenino , Adolescente , Humanos , Niño , Estudios Retrospectivos , Pandemias , COVID-19/epidemiología , COVID-19/complicaciones , Disfunción de los Pliegues Vocales/epidemiología , Disfunción de los Pliegues Vocales/etiología , Disfunción de los Pliegues Vocales/diagnóstico , Pliegues Vocales , Ruidos Respiratorios/etiología
3.
J Korean Med Sci ; 37(25): e201, 2022 Jun 27.
Artículo en Inglés | MEDLINE | ID: covidwho-1911012

RESUMEN

Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was noted to cause coronavirus disease 2019 (COVID-19) in 2019, there have been many trials to develop vaccines against the virus. Messenger ribonucleic acid (mRNA) vaccine as a type of the vaccine has been developed and commercialized rapidly, but there was not enough time to verify the long-term safety. An 82-year-old female patient was admitted to the emergency room with dyspnea accompanied by stridor three days after the 3rd COVID-19 mRNA vaccination (Comirnaty, Pfizer-BioNTech, USA). The patient was diagnosed with bilateral vocal fold paralysis (VFP) by laryngoscope. Respiratory distress was improved after the intubation and tracheostomy in sequence. The brain, chest, and neck imaging tests, serological tests, cardiological analysis, and immunological tests were performed to evaluate the cause of bilateral VFP. However, no definite cause was found except for the precedent vaccination. Because bilateral VFP can lead to a fatal condition, a quick evaluation is necessary in consideration of VFP when dyspnea with stridor occurs after vaccination.


Asunto(s)
COVID-19 , Parálisis de los Pliegues Vocales , Anciano de 80 o más Años , COVID-19/diagnóstico , Disnea/etiología , Femenino , Humanos , ARN Mensajero , Ruidos Respiratorios/etiología , SARS-CoV-2 , Vacunación/efectos adversos , Parálisis de los Pliegues Vocales/diagnóstico , Parálisis de los Pliegues Vocales/etiología , Pliegues Vocales
5.
J Acoust Soc Am ; 151(5): 2987, 2022 05.
Artículo en Inglés | MEDLINE | ID: covidwho-1861565

RESUMEN

In an effort to mitigate the 2019 novel coronavirus disease pandemic, mask wearing and social distancing have become standard practices. While effective in fighting the spread of the virus, these protective measures have been shown to deteriorate speech perception and sound intensity, which necessitates speaking louder to compensate. The goal of this paper is to investigate via numerical simulations how compensating for mask wearing and social distancing affects measures associated with vocal health. A three-mass body-cover model of the vocal folds (VFs) coupled with the sub- and supraglottal acoustic tracts is modified to incorporate mask and distance dependent acoustic pressure models. The results indicate that sustaining target levels of intelligibility and/or sound intensity while using these protective measures may necessitate increased subglottal pressure, leading to higher VF collision and, thus, potentially inducing a state of vocal hyperfunction, a progenitor to voice pathologies.


Asunto(s)
COVID-19 , Voz , COVID-19/prevención & control , Humanos , Fonación , Vibración , Pliegues Vocales
7.
ANZ J Surg ; 92(3): 385-389, 2022 03.
Artículo en Inglés | MEDLINE | ID: covidwho-1672962

RESUMEN

BACKGROUND: Clinical voice assessment prior to thyroid and parathyroid surgery is essential, but the paradigm of indirect laryngoscopy (IDL), when indicated, has been challenged by the risk of aerosolised SARS-Cov-2 during endoscopy of the aerodigestive tract. Translaryngeal ultrasound (TLUS) to assess the vocal cords has been proposed as a safe, non-invasive and sensitive alternative. The aim of this review was to verify TLUS as a viable tool for perioperative laryngeal assessment. METHOD: A literature review was performed using Medline, Embase, Cochrane Database of Systematic Reviews, Cochrane Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials and Scopus with the following search strategy: (vocal cord OR vocal fold OR glottic OR glottis OR vocal ligaments OR rima glottidis) AND (ultras* OR sonograph* OR echography OR echotomography). RESULTS: Fifteen studies were included in this review. All studies compared TLUS to IDL in visualizing the vocal cords in adults. Ten studies compared pre-operative TLUS to IDL where 50.6-100% of vocal cords were successfully visualized. Nine studies compared post-operative TLUS to IDL and reported visualization between 39.6% and 100%. Pre- and post-operative negative predictive values ranged from 60% to 100%. CONCLUSION: Whilst promising, successful visualization of the cords is limited by inter-user variability, older age and male gender. Thus, we see the role of TLUS as an alternative to IDL in the post-operative setting in the young patient following uncomplicated surgery with a normal voice on clinical examination, to confirm recurrent laryngeal nerve integrity while minimizing the risk of aerosolization.


Asunto(s)
COVID-19 , Parálisis de los Pliegues Vocales , Adulto , Humanos , Laringoscopía/métodos , Masculino , SARS-CoV-2 , Revisiones Sistemáticas como Asunto , Glándula Tiroides , Tiroidectomía/efectos adversos , Ultrasonografía/métodos , Parálisis de los Pliegues Vocales/diagnóstico por imagen , Parálisis de los Pliegues Vocales/etiología , Pliegues Vocales/diagnóstico por imagen
8.
Ann Otol Rhinol Laryngol ; 131(9): 1032-1035, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: covidwho-1467790

RESUMEN

OBJECTIVE: Evidence demonstrates neurotropism is a common feature of coronaviruses. In our laryngology clinics we have noted an increase in cases of "idiopathic" vocal fold paralysis and paresis in patients with no history of intubation who are recovering from the novel SARS-Cov-2 coronavirus (COVID-19). This finding is concerning for a post-viral vagal neuropathy (PVVN) as a result of infection with COVID-19. Our objective is to raise the possibility that vocal fold paresis may be an additional neuropathic sequela of infection with COVID-19. METHODS: Retrospective review of patients who tested positive for COVID-19, had no history of intubation as a result of their infection, and subsequently presented with vocal fold paresis between May 2020 and January 2021. Charts were reviewed for demographic information, confirmation of COVID-19 infection, presenting symptoms, laryngoscopy and stroboscopy exam findings, and laryngeal electromyography (LEMG) results. RESULTS: Sixteen patients presented with new-onset dysphonia during and after recovering from a COVID-19 infection and were found to have unilateral or bilateral vocal fold paresis or paralysis. LEMG was performed in 25% of patients and confirmed the diagnosis of neuropathy in these cases. CONCLUSIONS: We believe that COVID-19 can cause a PVVN resulting in abnormal vocal fold mobility. This diagnosis should be included in the constellation of morbidities that can result from COVID-19 as the otolaryngologist can identify this entity through careful history and examination.


Asunto(s)
COVID-19 , Paresia , Parálisis de los Pliegues Vocales , COVID-19/complicaciones , Electromiografía/métodos , Humanos , Paresia/diagnóstico , Paresia/etiología , SARS-CoV-2 , Parálisis de los Pliegues Vocales/diagnóstico , Parálisis de los Pliegues Vocales/etiología , Pliegues Vocales/patología
10.
Laryngoscope ; 131(11): 2545-2549, 2021 11.
Artículo en Inglés | MEDLINE | ID: covidwho-1198394

RESUMEN

OBJECTIVES/HYPOTHESIS: Vocal fold movement impairment (VFMI) in infants and children is most commonly evaluated by flexible nasolaryngoscopy (FNL). FNL in this population can be challenging due to movement, floppy supraglottic structures, or secretions. Laryngeal ultrasound (LUS) may be an alternative, less invasive means of evaluating VFMI that also decreases aerosolization during the COVID-19 pandemic. The primary objective was to examine LUS interpretation proficiency for VFMI via an educational module. A secondary outcome was to determine whether quantitative measurements increase interpretation accuracy. STUDY DESIGN: Prospective cohort trial. METHODS: Medical students, residents, fellows, faculty, and staff were recruited to complete the module, composed of a 13-minute teaching video followed by 20 cases. Participants determined both qualitatively (subjective assessment) and then quantitatively (through protractor measurements of the vocal fold to arytenoid angle) whether there was normal versus impaired vocal fold mobility. RESULTS: Thirty participants completed the LUS training module, and about one-third were otolaryngology residents. On average, each participant correctly identified 18 cases. The mean rank percent correct for quantitative measurements was significantly higher than that of qualitative interpretations (P < .0001). Measurements significantly caused participants to change their answer correctly compared to incorrectly (P < .0001). As the module progressed, there was no significant trend of more correct interpretations (P = .30). The sensitivity was higher for quantitative interpretations (89.0% vs. 87.3%) but specificity remained unchanged (92.6%). CONCLUSION: Quantitative measurements may increase LUS interpretation accuracy. There was not a specific number of cases interpreted to achieve learning proficiency. LUS is an easily learned method to evaluate for VFMI across all training levels. LEVEL OF EVIDENCE: 3 (local cohort study nonrandomized) Laryngoscope, 131:2545-2549, 2021.


Asunto(s)
Laringe/diagnóstico por imagen , Preceptoría/métodos , Ultrasonografía/métodos , Pliegues Vocales/diagnóstico por imagen , Aerosoles/efectos adversos , COVID-19/diagnóstico , COVID-19/epidemiología , COVID-19/transmisión , COVID-19/virología , Niño , Estudios de Cohortes , Estudios de Evaluación como Asunto , Humanos , Lactante , Laringe/anatomía & histología , Laringe/fisiología , Masculino , Evaluación de Resultado en la Atención de Salud , Estudios Prospectivos , SARS-CoV-2/genética , Sensibilidad y Especificidad , Pliegues Vocales/fisiopatología
11.
Am J Case Rep ; 21: e928126, 2020 Nov 04.
Artículo en Inglés | MEDLINE | ID: covidwho-910296

RESUMEN

BACKGROUND This report is of a case of vocal cord ulceration following endotracheal intubation and mechanical ventilation in a patient with severe COVID-19 pneumonia. CASE REPORT A 57-year-old woman was admitted to our hospital (Ospedale Degli Infermi, Biella, Italy) presenting with symptoms of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Reverse transcription real-time polymerase chain reaction from a nasopharyngeal swab, authorized and validated by the World Health Organization, confirmed the diagnosis of SARS-CoV-2 infection. The patient presented with severe respiratory distress and underwent orotracheal intubation for mechanical ventilation. She was extubated after 9 days in the intensive care unit. After extubation, the patient experienced an onset of dysphonia, and was evaluated by the otolaryngologist. The videolaryngoscopy revealed the presence of an ulceration at the level of the left vocal cord. Steroids and proton pump inhibitors were administered as primary therapy for 1 week. Two weeks later, a significant improvement in the patient's voice quality was observed. A second videolaryngoscopy was performed, which displayed healing of the ulcer at the level of the left vocal fold and rapid re-epithelialization. CONCLUSIONS This report has shown that with increasing numbers of cases of severe COVID-19 pneumonia requiring endotracheal intubation and mechanical ventilation, clinical guidelines should be followed to ensure that the incidence of complications such as vocal cord ulceration are as low as possible.


Asunto(s)
COVID-19/terapia , Intubación Intratraqueal/efectos adversos , Respiración Artificial/efectos adversos , SARS-CoV-2 , Úlcera/etiología , Pliegues Vocales/lesiones , COVID-19/epidemiología , Femenino , Humanos , Italia , Persona de Mediana Edad , Pandemias , Úlcera/diagnóstico
12.
Head Neck ; 42(6): 1131-1136, 2020 06.
Artículo en Inglés | MEDLINE | ID: covidwho-66373

RESUMEN

BACKGROUND AND METHODS: There is an added level of complexity in the management of head and neck cancer patients with underlying immunosuppressive disorders during the COVID-19 pandemic. Head and neck oncologists are tasked with balancing the dual risks of cancer progression in the setting of impaired tumor immunity and increased susceptibility to life-threatening complications from exposure to viral infection for patients and providers. Through two cases of immunocompromised patients with newly diagnosed head and neck malignancies, we aim to provide guidance to clinicians struggling with how to best counsel and manage this unique subset of patients under these difficult circumstances. RESULTS: After careful consideration of the options, we took different approaches in the care of these two patients. CONCLUSIONS: Ultimately, there is no uniform set of rules to apply to this heterogeneous group of immunocompromised patients. We provide some general principles to help guide patient management during the current pandemic.


Asunto(s)
Tratamiento Conservador/métodos , Infecciones por Coronavirus/epidemiología , Neoplasias de Cabeza y Cuello/terapia , Huésped Inmunocomprometido , Pandemias/prevención & control , Neumonía Viral/epidemiología , Tiempo de Tratamiento/organización & administración , Adulto , COVID-19 , Toma de Decisiones Clínicas , Control de Enfermedades Transmisibles/métodos , Manejo de la Enfermedad , Femenino , Estudios de Seguimiento , Neoplasias de Cabeza y Cuello/patología , Humanos , Comunicación Interdisciplinaria , Neoplasias Laríngeas/patología , Neoplasias Laríngeas/cirugía , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/patología , Neoplasias de la Boca/cirugía , Seguridad del Paciente , Medición de Riesgo , Muestreo , Factores de Tiempo , Estados Unidos , Pliegues Vocales/patología , Pliegues Vocales/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA